The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CANDEL THERAPEUTICS INC | COM | 137404109 | 3,464,035 | 1,935,215 | SH | SOLE | 1,935,215 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 102,737,575 | 3,292,871 | SH | SOLE | 3,292,871 | 0 | 0 | ||
ISOPLEXIS CORP | COM | 465005106 | 13,653,223 | 8,808,531 | SH | SOLE | 8,808,531 | 0 | 0 | ||
TELESIS BIO INC | COM | 192003101 | 11,812,956 | 9,844,130 | SH | SOLE | 9,844,130 | 0 | 0 | ||
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 52,681,225 | 4,214,498 | SH | SOLE | 4,214,498 | 0 | 0 |